BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30447218)

  • 1. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L
    Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural flavonoid galangin alleviates microglia-trigged blood-retinal barrier dysfunction during the development of diabetic retinopathy.
    Zhang T; Mei X; Ouyang H; Lu B; Yu Z; Wang Z; Ji L
    J Nutr Biochem; 2019 Mar; 65():1-14. PubMed ID: 30597356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells
    Zhang T; Ouyang H; Mei X; Lu B; Yu Z; Chen K; Wang Z; Ji L
    FASEB J; 2019 Nov; 33(11):11776-11790. PubMed ID: 31365278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorogenic acid improves diabetic retinopathy by alleviating blood-retinal-barrier dysfunction via inducing Nrf2 activation.
    Ouyang H; Du A; Zhou L; Zhang T; Lu B; Wang Z; Ji L
    Phytother Res; 2022 Mar; 36(3):1386-1401. PubMed ID: 35133045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asiatic acid attenuates diabetic retinopathy through TLR4/MyD88/NF-κB p65 mediated modulation of microglia polarization.
    Fang M; Wan W; Li Q; Wan W; Long Y; Liu H; Yang X
    Life Sci; 2021 Jul; 277():119567. PubMed ID: 33965378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid ameliorates diabetic retinopathy via reducing retinal inflammation and reversing the breakdown of blood-retinal barrier.
    Ouyang H; Mei X; Zhang T; Lu B; Ji L
    Eur J Pharmacol; 2018 Dec; 840():20-27. PubMed ID: 30268667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chemokine Platelet Factor-4 Variant (PF-4var)/CXCL4L1 Inhibits Diabetes-Induced Blood-Retinal Barrier Breakdown.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Abdelsaid M; Siddiquei MM; Alam K; Van den Eynde K; De Hertogh G; Opdenakker G; Al-Shabrawey M; Van Damme J; Struyf S
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1956-64. PubMed ID: 25711636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
    Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consumption of Polyphenol-Rich Zingiber Zerumbet Rhizome Extracts Protects against the Breakdown of the Blood-Retinal Barrier and Retinal Inflammation Induced by Diabetes.
    Tzeng TF; Hong TY; Tzeng YC; Liou SS; Liu IM
    Nutrients; 2015 Sep; 7(9):7821-41. PubMed ID: 26389948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
    Huang H; Gandhi JK; Zhong X; Wei Y; Gong J; Duh EJ; Vinores SA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1336-44. PubMed ID: 21212173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.
    Zhu SH; Liu BQ; Hao MJ; Fan YX; Qian C; Teng P; Zhou XW; Hu L; Liu WT; Yuan ZL; Li QP
    Inflammation; 2017 Oct; 40(5):1475-1486. PubMed ID: 28639050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway.
    Wang D; Wang L; Gu J; Yang H; Liu N; Lin Y; Li X; Shao C
    J Cardiovasc Pharmacol; 2014 Sep; 64(3):218-27. PubMed ID: 25192544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.
    Fu D; Yu JY; Connell AR; Hookham MB; McLeese RH; Lyons TJ
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):754-764. PubMed ID: 33107777
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.
    El-Remessy AB; Al-Shabrawey M; Khalifa Y; Tsai NT; Caldwell RB; Liou GI
    Am J Pathol; 2006 Jan; 168(1):235-44. PubMed ID: 16400026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scutellarein alleviates the dysfunction of inner blood-retinal-barrier initiated by hyperglycemia-stimulated microglia cells.
    Li H; Mei XY; Wang MN; Zhang TY; Zhang Y; Lu B; Sheng YC
    Int J Ophthalmol; 2020; 13(10):1538-1545. PubMed ID: 33078102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
    Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
    Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling.
    Long L; Li Y; Yu S; Li X; Hu Y; Long T; Wang L; Li W; Ye X; Ke Z; Xiao H
    J Diabetes Res; 2019; 2019():4875421. PubMed ID: 31976335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between microglia and retinal pigment epithelial cells determines the integrity of outer blood-retinal barrier in diabetic retinopathy.
    Jo DH; Yun JH; Cho CS; Kim JH; Kim JH; Cho CH
    Glia; 2019 Feb; 67(2):321-331. PubMed ID: 30444022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
    Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.